Parexel News (NASDAQ:PRXL)

DateTimeSource
Headline
12/01/201611:45AMPRNUSLifshitz & Miller Law Firm Announces Investigation of Georgetown Bancorp, Inc., Lattice Semiconductor Corporation, Mallinckro...
Lifshitz & Miller Law Firm Announces Investigation of Georgetown Bancorp, Inc., Lattice Semiconductor Corporation, Mallinckrodt Public Limited Company, Mentor Graphics Corporation, PAREXEL International Corporation, Resource Capital Corp., Southwestern Energy Company and Team Health Holdings, Inc. PR Newswire NEW YORK... More...>>
11/22/201610:09AMBWPAREXEL International Announces $200 Million Accelerated Share Repurchase Program
PAREXEL International Corporation (Nasdaq:PRXL), a leading global biopharmaceutical services provider, announced today that the Company entered into an accelerated share repurchase agreement (ASR) with HSBC Bank USA, National Association, to purchase shares of its common stock for an aggregate purchase price of $200 million... More...>>
11/16/20169:00AMBWPAREXEL International to Participate in Evercore ISI MedTools Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be attending the Evercore ISI MedTools Conference in Boston. Josef von Rickenbach, Chairman and Chief Executive Officer, will participate on Wednesday, November 30, 2016. About PAREXEL InternationalPAREXEL International Corporation is a leading... More...>>
11/15/20163:41PMPRNUSHarwood Feffer LLP Announces Investigation of PAREXEL International Corporation
Harwood Feffer LLP Announces Investigation of PAREXEL International Corporation PR Newswire NEW YORK, Nov. 15, 2016 NEW YORK, Nov. 15, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of PAREXEL International Corporation ("PAREXEL" or the "Company... More...>>
11/14/20165:30PMBWBragar Eagel & Squire, P.C. Is Investigating PAREXEL International Corp. (PRXL) on Behalf of Stockholders & Encourages Invest...
Bragar Eagel & Squire, P.C. is investigating potential claims against PAREXEL International Corporation (NASDAQ:PRXL) concerning possible violations of the federal securities laws. On August 30, 2016, post-market, PAREXEL announced that the Company was postponing the filing of its 2016 Annual Report on Form 10-K after... More...>>
11/14/201612:07PMBWSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Violations of Federal Securities Laws...
Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ: PRXL) (“PAREXEL”) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. On August 30, 2016, PAREXEL announced that it would be delaying its... More...>>
11/14/201610:50AMBWIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of PAREXEL International Corporation
Khang & Khang LLP (the “Firm”) announces that it is investigating claims against PAREXEL International Corporation (“PAREXEL” or the “Company”) (Nasdaq: PRXL) concerning possible violations of federal securities laws. If you purchased shares of PAREXEL and want more information free of charge, please contact... More...>>
11/14/201610:15AMPRNUSSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PAREXEL International Corporation (PRXL)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PAREXEL International Corporation (PRXL) PR Newswire NEW YORK, Nov. 14, 2016 NEW YORK, Nov. 14, 2016 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers... More...>>
11/14/20169:00AMBWPAREXEL Launches IDMP-Focused Software and Service Solution
Solution developed to help biopharmaceutical companies meet emerging regulatory requirements ahead of deadline PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched an Identification of Medicinal Products (IDMP)-focused solution for biopharmaceutical companies... More...>>
11/11/20167:38PMBWEQUITY ALERT: Goldberg Law PC Announces an Investigation of Claims against PAREXEL International Corp. & Advises Investors wi...
Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating PAREXEL International Corporation (“PAREXEL” or the “Company”) (Nasdaq: PRXL) concerning possible violations of federal securities laws. If you purchased or otherwise acquired PAREXEL shares and would like more information... More...>>
11/11/20166:52PMBWGlancy Prongay & Murray LLP Commences Investigation on Behalf of PAREXEL International Corporation Investors
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of PAREXEL International Corporation (“PAREXEL” or the “Company”) (NASDAQ: PRXL) investors concerning the Company and its officers’ possible violations of federal securities laws. On August 30, 2016, post-market, PAREXEL announced... More...>>
11/11/20166:41PMBWINVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against PAREXEL International Corp. - PRXL
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PAREXEL International Corporation (NASDAQ:PRXL) resulting from allegations that PAREXEL may have issued materially misleading business information to the investing public. On November... More...>>
11/11/20161:06PMPRNUSWolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in PAREXEL International Corp.
Wolf Popper LLP Announces Investigation of Fraud Claims on Behalf of Investors in PAREXEL International Corp. PR Newswire NEW YORK, Nov. 11, 2016 NEW YORK, Nov. 11, 2016 /PRNewswire-USNewswire/ -- Wolf Popper LLP is investigating potential claims on behalf of investors in PAREXEL International Corp. (NASDAQ: PRXL), resulting... More...>>
11/11/201612:52PMBWINVESTOR ALERT: Lundin Law PC Announces an Investigation of PAREXEL International Corp. & Advises Investors with Losses to Co...
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against PAREXEL International Corporation (“PAREXEL” or the “Company”) (Nasdaq: PRXL) concerning possible violations of federal securities laws. To get more information about this investigation, please contact Brian Lundin, Esquire... More...>>
11/11/201611:58AMPRNUSSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PAREXEL International Corporation - PRXL
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PAREXEL International Corporation - PRXL PR Newswire NEW YORK, Nov. 11, 2016 NEW YORK, Nov. 11, 2016 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PAREXEL International Corporation ("PAREXEL" or the "Company... More...>>
10/26/20164:02PMBWPAREXEL International Reports First Quarter Fiscal Year 2017 Results and Announces New Share Repurchase Program
First Quarter Fiscal Year 2017 Results (compared to First Quarter Fiscal Year 2016) GAAP diluted earnings per share of $0.75, up 66.7%; adjusted earnings per share of $0.76, up 8.6% Service revenue of $500.9 million, down 2.2%; constant currency revenue decline of 2.4% Gross new business of $930 million Company guides... More...>>
10/24/20169:00AMBWPAREXEL International to Present at Credit Suisse Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Credit Suisse Healthcare Conference in Phoenix, AZ. Emma Reeve, Corporate Vice President and Interim Chief Financial Officer, will be making a presentation on PAREXEL and discuss business developments at 10:00 a.m. MT on... More...>>
10/13/20169:00AMBWPAREXEL International Announces Date of First Quarter Fiscal Year 2017 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for First Quarter Fiscal Year 2017 on Wednesday, October 26, 2016 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, October 27, 2016, to discuss the results. To access the... More...>>
10/06/20169:00AMBWPAREXEL Launches Active Tracking Service for Monitoring and Managing Temperature-Controlled Investigational Medicinal Products
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the launch of its Active Tracking service. The service follows Good Distribution Practice (GDP) requirements by providing biopharmaceutical companies with near real-time temperature and location monitoring... More...>>
09/26/20169:00AMBWPAREXEL Announces Execution of Definitive Agreement to Acquire ExecuPharm
Acquisition will strengthen and add scale to current functional services offering to meet growing demand PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc. (“ExecuPharm”... More...>>
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20161210 14:40:55